Pharmacists in Central City, NE Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Allyn Komorowski, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1715 26th St, Central City, NE 68826 Phone: 308-946-3015 |
 Travis V Kuchar, PHARM.D, R.P. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 16th St, Central City, NE 68826 Phone: 308-946-3859 Fax: 308-946-3850 |
Norman Balliet, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 16th St, Central City, NE 68826 Phone: 308-946-3859 Fax: 308-946-3850 |
Ronald Leon Schafer, R.P. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1715 26th St, Central City, NE 68826 Phone: 308-946-5981 Fax: 308-946-5911 |
Reginald Lee Hain, R.P. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1715 26th St, Central City, NE 68826 Phone: 308-946-5981 Fax: 308-946-5911 |
News Archive
Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Why Primary Cells Are Important for In Vitro ADME-Tox Studies
Lonza is a large, multinational corporation serving the entire pharmaceutical product development and manufacturing pipeline, from non-clinical research products to final dosage and delivery solutions.
fMRI can predict language development outcomes in ASD toddlers
Using functional magnetic resonance imaging (fMRI), University of California, San Diego School of Medicine researchers say it may be possible to predict future language development outcomes in toddlers with autistic spectrum disorder (ASD), even before they've been formally diagnosed with the condition.
Two leading biotechnology companies collaborate to gain further understanding of Parkinson's disease
This week 23andMe (a genetic testing company) and Genentech (medical research company of the Roche Group) agreed a collaboration to undertake whole genome sequencing for 3,000 patients with Parkinson's disease. The genetic information will be collected by 23andMe and used by Genentech to identify new therapeutic targets for treating Parkinson's disease.
› Verified 2 days ago
Dentists
Pharmacists
Psychologists
Occupational Therapists
Counselors